Research Trial for Alopecia Areata (32 Weeks)

Adults aged 18-65 with a definitive diagnosis of alopecia areata with a current episode of scalp hair loss lasting at least 6 months (not exceeding 10 years), may qualify to participate. Total disease duration greater than 10 years is permitted. Individuals must have at least 50% scalp hair loss.

Participants will receive investigational oral medication (active study drug) or placebo. Investigational medication and study-related care will be provided at no cost. Reimbursement for study-related expenses may also be provided.

Study participation will last about 32 weeks and involve about 10 visits to the study centre.

Call the study centre near you, or register now

Learn more about
Alopecia
Register Now!

Register for
Active Studies!

Register

All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more